Articles from Stoked Bio Inc.

Stoked Bio Secures Exclusive Global License to Develop a Promising New Therapy for Crohn’s Disease
Enterololin, a narrow-spectrum antibiotic uses a novel mechanism of action to attack the infection
By Stoked Bio Inc. · Via GlobeNewswire · February 18, 2026